Anne Hamik

Publications (21)140.32 Total impact

• Article: Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice.

  Guangjin Zhou, Anne Hamik, Lalitha Nayak, Hongmei Tian, Hong Shi, Yuan Lu, Nikunj Sharma, Xudong Liao, Andrew Hale, Lauren Boerboom, Ryan E Feaver, Huiyun Gao, Amar Desai, Alvin Schmaier, Stanton L Gerson, Yunmei Wang, G Brandon Atkins, Brett R Blackman, Daniel I Simon, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: The endothelium regulates vascular homeostasis, and endothelial dysfunction is a proximate event in the pathogenesis of atherothrombosis. Stimulation of the endothelium with proinflammatory cytokines or exposure to hemodynamic-induced disturbed flow leads to a proadhesive and prothrombotic phenotype that promotes atherothrombosis. In contrast, exposure to arterial laminar flow induces a gene program that confers a largely antiadhesive, antithrombotic effect. The molecular basis for this differential effect on endothelial function remains poorly understood. While recent insights implicate Kruppel-like factors (KLFs) as important regulators of vascular homeostasis, the in vivo role of these factors in endothelial biology remains unproven. Here, we show that endothelial KLF4 is an essential determinant of atherogenesis and thrombosis. Using in vivo EC-specific KLF4 overexpression and knockdown murine models, we found that KLF4 induced an antiadhesive, antithrombotic state. Mechanistically, we demonstrated that KLF4 differentially regulated pertinent endothelial targets via competition for the coactivator p300. These observations provide cogent evidence implicating endothelial KLFs as essential in vivo regulators of vascular function in the adult animal.
  The Journal of clinical investigation 11/2012; · 15.39 Impact Factor
• Article: MiRrored regulation of KLF2 and KLF4.

  Anne Hamik, Mukesh K Jain
  Arteriosclerosis Thrombosis and Vascular Biology 04/2012; 32(4):839-40. · 6.37 Impact Factor
• Article: Endothelial differentiation: molecular mechanisms of specification and heterogeneity.

  G Brandon Atkins, Mukesh K Jain, Anne Hamik
  [show abstract] [hide abstract]
  ABSTRACT: A complex and diverse vascular system is requisite for the survival of higher organisms. The process of vascular development is highly regulated, involving the de novo formation of vessels (vasculogenesis), followed by expansion and remodeling of the primitive vasculature (angiogenesis), culminating in differentiation of endothelial phenotypes, as found in the mature vascular system. Over the last decade, significant advances have been made in understanding the molecular regulation of endothelial cell development and differentiation. Endothelial development, in particular the mechanisms in play during vasculogenesis and angiogenesis, is discussed in a sister review to this article. This review highlights the key pathways governing in endothelial differentiation, with a focus on the major molecular mechanisms of endothelial specification and heterogeneity.
  Arteriosclerosis Thrombosis and Vascular Biology 07/2011; 31(7):1476-84. · 6.37 Impact Factor
• Article: Krüppel-like factor 4 regulates macrophage polarization.

  Xudong Liao, Nikunj Sharma, Fehmida Kapadia, Guangjin Zhou, Yuan Lu, Hong Hong, Kaavya Paruchuri, Ganapati H Mahabeleshwar, Elise Dalmas, Nicolas Venteclef, Chris A Flask, Julian Kim, Bryan W Doreian, Kurt Q Lu, Klaus H Kaestner, Anne Hamik, Karine Clément, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: Current paradigms suggest that two macrophage subsets, termed M1 and M2, are involved in inflammation and host defense. While the distinct functions of M1 and M2 macrophages have been intensively studied - the former are considered proinflammatory and the latter antiinflammatory - the determinants of their speciation are incompletely understood. Here we report our studies that identify Krüppel-like factor 4 (KLF4) as a critical regulator of macrophage polarization. Macrophage KLF4 expression was robustly induced in M2 macrophages and strongly reduced in M1 macrophages, observations that were recapitulated in human inflammatory paradigms in vivo. Mechanistically, KLF4 was found to cooperate with Stat6 to induce an M2 genetic program and inhibit M1 targets via sequestration of coactivators required for NF-κB activation. KLF4-deficient macrophages demonstrated increased proinflammatory gene expression, enhanced bactericidal activity, and altered metabolism. Furthermore, mice bearing myeloid-specific deletion of KLF4 exhibited delayed wound healing and were predisposed to developing diet-induced obesity, glucose intolerance, and insulin resistance. Collectively, these data identify KLF4 as what we believe to be a novel regulator of macrophage polarization.
  The Journal of clinical investigation 06/2011; 121(7):2736-49. · 15.39 Impact Factor
• Article: Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors.

  Kristi L Allen, Anne Hamik, Mukesh K Jain, Keith R McCrae
  [show abstract] [hide abstract]
  ABSTRACT: Antiphospholipid syndrome is characterized by thrombosis and/or recurrent pregnancy loss in the presence of antiphospholipid antibodies (APLAs). The majority of APLAs are directed against phospholipid-binding proteins, particularly β₂-glycoprotein I (β₂GPI). Anti-β₂GPI antibodies activate endothelial cells in a β₂GPI-dependent manner through a pathway that involves NF-κB. Krüppel-like factors (KLFs) play a critical role in regulating the endothelial response to inflammatory stimuli. We hypothesized that activation of endothelial cells by APLA/anti-β₂GPI antibodies might be associated with decreased expression of KLFs, which in turn might facilitate cellular activation mediated through NF-κB. Our experimental results confirmed this hypothesis, demonstrating markedly decreased expression of KLF2 and KLF4 after incubation of cells with APLA/anti-β₂GPI antibodies. Restoration of KLF2 or KLF4 levels inhibited NF-κB transcriptional activity and blocked APLA/anti-β₂GPI-mediated endothelial activation despite NF-κB p65 phosphorylation. Chromatin immunoprecipitation analysis demonstrated that inhibition of NF-κB transcriptional activity by KLFs reflects sequestration of the cotranscriptional activator CBP/p300, making this cofactor unavailable to NF-κB. These findings suggest that the endothelial response to APLA/anti-β₂GPI antibodies reflects competition between KLFs and NF-κB for their common cofactor, CBP/p300. Taken together, these observations are the first to implicate the KLFs as novel participants in the endothelial proinflammatory response to APLA/anti-β₂GPI antibodies.
  Blood 06/2011; 117(23):6383-91. · 9.90 Impact Factor
• Article: Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis.

  Jinjing Zhao, Weiye Wang, Chang Hoon Ha, Ji Young Kim, Chelsea Wong, Eileen M Redmond, Anne Hamik, Mukesh K Jain, Gen-Sheng Feng, Zheng Gen Jin
  [show abstract] [hide abstract]
  ABSTRACT: Grb2-associated binder 1 (Gab1), a scaffolding adaptor protein, plays an important role in transmitting key signals that control cell growth, differentiation, and function from multiple tyrosine kinase receptors. The study was designed to investigate the role of endothelial Gab1 in angiogenesis and its underlying molecular mechanisms. Using Cre-Lox recombination technology, we generated endothelial-specific Gab1 knockout (Gab1-ecKO) mice. Gab1-ecKO mice are viable and showed no obvious developmental defects in the vascular system. To analyze the role of Gab1 in postnatal angiogenesis, we used hindlimb ischemia and Matrigel plug models. We found that loss of endothelial Gab1 in mice dramatically impaired postnatal angiogenesis. Gab1-ecKO mice had impaired ischemia-initiated blood flow recovery, exhibited reduced angiogenesis, and were associated with marked limb necrosis. We further observed significant endothelial cell (EC) death in the ischemic hindlimb of Gab1-ecKO mice. Matrigel plug assay showed that hepatocyte growth factor (HGF)-mediated angiogenesis was inhibited in Gab1-ecKO mice. In vitro studies showed that Gab1 was required for HGF-induced EC migration, tube formation, and microvessel sprouting. Mechanistically, HGF stimulated Gab1 tyrosine phosphorylation in ECs, leading to activation of extracellular regulated MAP kinase 1/2 and Akt, which are angiogenic and survival signaling. Gab1 is essential for postnatal angiogenesis through mediating angiogenic and survival signaling.
  Arteriosclerosis Thrombosis and Vascular Biology 03/2011; 31(5):1016-23. · 6.37 Impact Factor
• Article: Shear stress: devil's in the details.

  Anne Hamik, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: In this issue of Blood, Ni et al use an in vivo mouse model of disturbed flow that results in accelerated atherosclerosis to identify novel mechanosensitive genes.
  Blood 10/2010; 116(15):2625-6. · 9.90 Impact Factor
• Article: A novel role of CCN3 in regulating endothelial inflammation.

  Zhiyong Lin, Viswanath Natesan, Hong Shi, Anne Hamik, Daiji Kawanami, Caili Hao, Ganapati H Mahabaleshwar, Weiye Wang, Zheng-Gen Jin, G Brandon Atkins, Sue M Firth, Laure Rittié, Bernard Perbal, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: The vascular endothelium plays a fundamental role in the health and disease of the cardiovascular system. The molecular mechanisms regulating endothelial homeostasis, however, remain incompletely understood. CCN3, a member of the CCN (Cyr61, Ctgf, Nov) family of cell growth and differentiation regulators, has been shown to play an important role in numerous cell types. The function of CCN3 in endothelial cells has yet to be elucidated. Immunohistochemical analysis of CCN3 expression in mouse tissues revealed robust immunoreactivity in the endothelium of large arteries, small resistance vessels, and veins. We found that CCN3 expression in human umbilical vein endothelial cells (HUVECs) is transcriptionally induced by laminar shear stress (LSS) and HMG CoA-reductase inhibitors (statins). Promoter analyses identified the transcription factor Kruppel-like factor 2 (KLF2) as a direct regulator of CCN3 expression. In contrast to LSS, proinflammatory cytokines reduced CCN3 expression. Adenoviral overexpression of CCN3 in HUVEC markedly inhibited the cytokine-mediated induction of vascular adhesion molecule-1 (VCAM-1). Consistent with this observation, CCN3 significantly reduced monocyte adhesion. Conversely, CCN3 knockdown in HUVECs resulted in enhancement of cytokine-induced VCAM-1 expression. Concordant effects were observed on monocyte adhesion. Gain and loss-of-function mechanistic studies demonstrated that CCN3 negatively regulates nuclear factor kappaB (NF-κB) activity by reducing its translocation into the nucleus and subsequent binding to the VCAM-1 promoter, suggesting that CCN3's anti-inflammatory effects occur secondary to inhibition of NF-κB nuclear accumulation. This study identifies CCN3 as a novel regulator of endothelial proinflammatory activation.
  Journal of Cell Communication and Signaling 10/2010; 4(3):141-53.
• Article: PLDing a case for angiogenesis.

  Anne Hamik, Mukesh K Jain
  Blood 08/2010; 116(8):1194-6. · 9.90 Impact Factor
• Article: Conditional deletion of Cited2 results in defective corneal epithelial morphogenesis and maintenance.

  Yu Chen, Eric C Carlson, Zhi-Yi Chen, Anne Hamik, Mukesh K Jain, Sally L Dunwoodie, Yu-Chung Yang
  [show abstract] [hide abstract]
  ABSTRACT: Cited2 is an important transcriptional cofactor involved in multiple organ development. Gene profile analysis has identified Cited2 as one of the transcription factors expressed at high levels in adult mouse cornea. To address the function of Cited2 in corneal morphogenesis, we deleted Cited2 in surface ectoderm derived ocular structures including cornea by crossing Cited2-floxed mice with Le-Cre transgenic mice. Cited2(flox/flox);Le-Cre(+) eyes invariably displayed corneal opacity and developed spontaneous corneal neovascularization at older age. Fewer layers of corneal epithelial cells and the absence of cytokeratin 12 (K12) expression featured Cited2 deficient postnatal and adult eyes. Cited2 deficient cornea exhibited impaired healing in response to corneal epithelial debridement by manifesting abnormal histology, lack of K12 expression and corneal neovascularization. Moreover, mechanistic studies suggest that Cited2 may play a role in corneal morphogenesis in part through modulating the expression of Pax6 and Klf4. Collectively, these findings demonstrate a novel function of Cited2 in postnatal corneal morphogenesis and maintenance. Our study will help better understand the molecular mechanisms involved in corneal biology, and more importantly, it may provide a valuable animal model for testing therapeutics in the treatment of corneal disorders, especially blindness as a result of corneal epithelial cell deficiency.
  Developmental Biology 08/2009; 334(1):243-52. · 4.07 Impact Factor
• Article: Kruppel-like Factor 2 Inhibits Hypoxia-inducible Factor 1α Expression and Function in the Endothelium

  Daiji Kawanami, Ganapati H. Mahabeleshwar, Zhiyong Lin, G. Brandon Atkins, Anne Hamik, Saptarsi M. Haldar, Koji Maemura, Joseph C. LaManna, Mukesh K. Jain
  [show abstract] [hide abstract]
  ABSTRACT: Hypoxia-inducible factor 1 (HIF-1) is a central regulator of the hypoxic response in many cell types. In endothelial cells, HIF-1 induces the expression of key proangiogenic factors to promote angiogenesis. Recent studies have identified Kruppel-like factor 2 (KLF2) as a potent inhibitor of angiogenesis. However, the role of KLF2 in regulating HIF-1 expression and function has not been evaluated. KLF2 expression was induced acutely by hypoxia in endothelial cells. Adenoviral overexpression of KLF2 inhibited hypoxia-induced expression of HIF-1α and its target genes such as interleukin 8, angiopoietin-2, and vascular endothelial growth factor in endothelial cells. Conversely, knockdown of KLF2 increased expression of HIF-1α and its targets. Furthermore, KLF2 inhibited hypoxia-induced endothelial tube formation, whereas endothelial cells from mice with haploinsufficiency of KLF2 showed increased tube formation in response to hypoxia. Consistent with this ex vivo observation, KLF2 heterozygous mice showed increased microvessel density in the brain. Mechanistically, KLF2 promoted HIF-1α degradation in a von Hippel-Lindau protein-independent but proteasome-dependent manner. Finally, KLF2 disrupted the interaction between HIF-1α and its chaperone Hsp90, suggesting that KLF2 promotes degradation of HIF-1α by affecting its folding and maturation. These observations identify KLF2 as a novel inhibitor of HIF-1α expression and function. Therefore, KLF2 may be a target for modulating the angiogenic response in disease states.
  Journal of Biological Chemistry 07/2009; 284(31):20522-20530. · 4.77 Impact Factor
• Article: Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium.

  Daiji Kawanami, Ganapati H Mahabeleshwar, Zhiyong Lin, G Brandon Atkins, Anne Hamik, Saptarsi M Haldar, Koji Maemura, Joseph C Lamanna, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: Hypoxia-inducible factor 1 (HIF-1) is a central regulator of the hypoxic response in many cell types. In endothelial cells, HIF-1 induces the expression of key proangiogenic factors to promote angiogenesis. Recent studies have identified Kruppel-like factor 2 (KLF2) as a potent inhibitor of angiogenesis. However, the role of KLF2 in regulating HIF-1 expression and function has not been evaluated. KLF2 expression was induced acutely by hypoxia in endothelial cells. Adenoviral overexpression of KLF2 inhibited hypoxia-induced expression of HIF-1alpha and its target genes such as interleukin 8, angiopoietin-2, and vascular endothelial growth factor in endothelial cells. Conversely, knockdown of KLF2 increased expression of HIF-1alpha and its targets. Furthermore, KLF2 inhibited hypoxia-induced endothelial tube formation, whereas endothelial cells from mice with haploinsufficiency of KLF2 showed increased tube formation in response to hypoxia. Consistent with this ex vivo observation, KLF2 heterozygous mice showed increased microvessel density in the brain. Mechanistically, KLF2 promoted HIF-1alpha degradation in a von Hippel-Lindau protein-independent but proteasome-dependent manner. Finally, KLF2 disrupted the interaction between HIF-1alpha and its chaperone Hsp90, suggesting that KLF2 promotes degradation of HIF-1alpha by affecting its folding and maturation. These observations identify KLF2 as a novel inhibitor of HIF-1alpha expression and function. Therefore, KLF2 may be a target for modulating the angiogenic response in disease states.
  Journal of Biological Chemistry 07/2009; 284(31):20522-30. · 4.77 Impact Factor
• Article: Prosthetic valve dysfunction presenting as intermittent acute aortic regurgitation.

  Dali Fan, Amgad N Makaryus, Anne Hamik, Aloke V Finn, Eric M Isselbacher
  [show abstract] [hide abstract]
  ABSTRACT: We describe the case of a 43 year old man with a history of aortic stenosis, for which he had undergone aortic valve replacement in 1991 with a 25-mm Medtronic Hall prosthesis. He presented with several acute episodes of dyspnea and flash pulmonary edema. Transthoracic and transesophageal echocardiography performed to evaluate prosthetic valve function revealed evidence of "intermittent" episodes of AI, documented on color M-mode flow mapping to have a variable duration of diastolic flow (early vs. pandiastolic) across the left ventricular outflow tract and the pulse wave Doppler in the descending thoracic aorta showed similar variability in the duration of diastolic flow reversal.
  Echocardiography 06/2008; 25(8):925-7. · 1.24 Impact Factor
• Article: Variety is the splice of life.

  Anne Hamik, Mukesh K Jain
  Journal of Molecular and Cellular Cardiology 02/2008; 44(1):44-6. · 5.17 Impact Factor
• Article: Kruppel-like factor 4 regulates endothelial inflammation.

  Anne Hamik, Zhiyong Lin, Ajay Kumar, Mercedes Balcells, Sumita Sinha, Jonathan Katz, Mark W Feinberg, Robert E Gerzsten, Elazer R Edelman, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: The vascular endothelium plays a critical role in vascular homeostasis. Inflammatory cytokines and non-laminar blood flow induce endothelial dysfunction and confer a pro-adhesive and pro-thrombotic phenotype. Therefore, identification of factors that mediate the effects of these stimuli on endothelial function is of considerable interest. Kruppel-like factor 4 expression has been documented in endothelial cells, but a function has not been described. In this communication we describe the expression in vitro and in vivo of Kruppel-like factor 4 in human and mouse endothelial cells. Furthermore, we demonstrate that endothelial Kruppel-like factor 4 is induced by pro-inflammatory stimuli and shear stress. Overexpression of Kruppel-like factor 4 induces expression of multiple anti-inflammatory and anti-thrombotic factors including endothelial nitric-oxide synthase and thrombomodulin, whereas knockdown of Kruppellike factor 4 leads to enhancement of tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 and tissue factor expression. The functional importance of Kruppel-like factor 4 is verified by demonstrating that Kruppel-like factor 4 expression markedly decreases inflammatory cell adhesion to the endothelial surface and prolongs clotting time under inflammatory states. Kruppel-like factor 4 differentially regulates the promoter activity of pro- and anti-inflammatory genes in a manner consistent with its anti-inflammatory function. These data implicate Kruppel-like factor 4 as a novel regulator of endothelial activation in response to pro-inflammatory stimuli.
  Journal of Biological Chemistry 06/2007; 282(18):13769-79. · 4.77 Impact Factor
• Article: Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression.

  Heiko Methe, Mercedes Balcells, Maria del Carmen Alegret, Marina Santacana, Blanca Molins, Anne Hamik, Mukesh K Jain, Elazer R Edelman
  [show abstract] [hide abstract]
  ABSTRACT: Endothelial cell phenotypes markedly differ, depending upon function and vascular bed of origin. Differences might account for specific susceptibility to pathological conditions. As leukocyte adhesion to activated endothelium is the initiating event in a range of diseases, we compared the influence of vascular bed-specific flow patterns on adhesion molecule expression in human saphenous vein (HSVEC) and coronary artery endothelial cells (HCAEC). In vitro, immune cell attachment was increased 1.6-fold when tumor necrosis factor (TNF)-alpha-stimulated HSVEC were exposed to coronary artery flow in place of physiological venous flow and 1.9-fold higher compared with attachment to cytokine-stimulated HCAEC exposed to coronary artery flow. This was associated with increased concentrations of soluble E-selectin, VCAM-1, and ICAM-1 in supernatants of HSVEC exposed to coronary artery flow compared with HCAEC exposed to the same flow pattern. Venous and coronary artery flow both increased TNF-alpha-induced E-selectin and ICAM-1 expression on HSVEC, but only coronary artery flow increased VCAM-1 expression. In marked contrast to HSVEC, venous and coronary artery flow attenuated TNF-alpha-induced E-selectin and VCAM-1 expression on HCAEC, whereas coronary artery flow further induced ICAM-1 on cytokine-stimulated HCAEC. With the exception of cytokine-induced ICAM-1, adhesion molecule expression on HSVEC exposed to coronary artery flow exceeded expression on HCAEC. Thus ICAM-1 expression involves complex flow-dependent and -independent pathways with marked dissimilarities between the two endothelial cell types studied. Interestingly, Kruppel-like factor (KLF) 4 overexpression in HCAEC and HSVEC significantly reduced TNF-alpha-induced E-selectin and VCAM-1 expression in static conditions, while ICAM-1 expression remained constant. Furthermore, both flow patterns induced KLF2 and KLF4 expression in HCAEC and HSVEC. Venous and coronary artery flow differentially influence endothelial adhesion molecule and transcription factor expression, depending on the vascular bed of origin. Differences in adhesion molecule expression and subsequent immune cell adhesion between HSVEC and HCAEC may contribute to different susceptibility to pathological conditions.
  AJP Heart and Circulatory Physiology 06/2007; 292(5):H2167-75. · 3.71 Impact Factor
• Article: Transcriptional regulators of angiogenesis.

  Anne Hamik, Baiqiu Wang, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: Angiogenesis, the process by which new blood vessels develop from a pre-existing vascular network, is essential for normal development and in certain physiological states. Inadequate or excessive angiogenesis has been incriminated in a number of pathologic states. For example, vaso-occlusive disease arising from atherosclerosis can lead to ischemia, a situation in which enhanced angiogenesis would be beneficial. Conversely, overzealous angiogenesis can contribute to tumor development and in this case inhibition of angiogenesis is desirable. Thus, strategies to induce or inhibit angiogenesis are of considerable therapeutic interest.
  Arteriosclerosis Thrombosis and Vascular Biology 10/2006; 26(9):1936-47. · 6.37 Impact Factor
• Article: Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation.

  Zhiyong Lin, Anne Hamik, Rajan Jain, Ajay Kumar, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: The serine protease thrombin can dramatically alter endothelial gene expression in a manner that confers a proinflammatory phenotype. Recent studies have identified the Kruppel-like factor 2 (KLF2) as a critical regulator of endothelial gene expression. Herein, we provide evidence that KLF2 inhibits thrombin-mediated endothelial activation via alterations in expression of its principal receptor protease-activated receptor-1 (PAR-1). Forced expression of KLF2 in human umbilical vein endothelial cells potently inhibited the ability of thrombin to induce multiple prothrombotic factors (tissue factor, CD40L, plasminogen activator inhibitor-1), cytokines/chemokines (eg, monocyte chemotactic protein-1, interleukin-6 [IL-6], IL-8), and matrix degrading enzymes (eg, matrix metalloproteinases 1, 2, and 9). Mechanistically, KLF2 inhibits PAR-1 expression and, as a consequence, thrombin-mediated nuclear factor kappaB (NF-kappaB) nuclear accumulation and DNA binding. Conversely, small interfering RNA-mediated knockdown of KLF2 increases PAR-1 expression and thrombin-mediated induction of NF-kappaB activation. These studies identify KLF2 as a novel regulator of PAR-1 expression and thrombin action in endothelial cells.
  Arteriosclerosis Thrombosis and Vascular Biology 06/2006; 26(5):1185-9. · 6.37 Impact Factor
• Article: Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2.

  Resham Bhattacharya, Sucharita Senbanerjee, Zhiyong Lin, Samy Mir, Anne Hamik, Ping Wang, Priyabrata Mukherjee, Debabrata Mukhopadhyay, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: The Kruppel-like factor KLF2 was recently identified as a novel regulator of endothelial pro-inflammatory and pro-thrombotic function. Here it is shown that overexpression of KLF2 potently inhibits vascular permeability factor/vascular endothelial growth factor (VEGF-A)-mediated angiogenesis and tissue edema in the nude ear mouse model of angiogenesis. In vitro, KLF2 expression retards VEGF-mediated calcium flux, proliferation and induction of pro-inflammatory factors in endothelial cells. This effect is due to a potent inhibition of VEGFR2/KDR expression and promoter activity. These observations identify KLF2 as a regulator of VEGFR2/KDR and provide a foundation for novel approaches to regulate angiogenesis.
  Journal of Biological Chemistry 09/2005; 280(32):28848-51. · 4.77 Impact Factor
• Article: Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.

  Sucharita Sen-Banerjee, Samy Mir, Zhiyong Lin, Anne Hamik, G Brandon Atkins, Hiranmoy Das, Pallab Banerjee, Ajay Kumar, Mukesh K Jain
  [show abstract] [hide abstract]
  ABSTRACT: Although 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are known to modulate endothelial function, the transcriptional mechanisms underlying these effects are incompletely understood. We hypothesized that Lung-Kruppel-like factor (LKLF/KLF2), a novel and potent regulator of endothelial gene expression, may mediate the downstream effects of statins. Here we report that statin-induced expression of endothelial NO synthase (eNOS) and thrombomodulin is KLF2 dependent. KLF2 mRNA was induced by treatment with multiple statins in a concentration-dependent manner. Multiple lines of evidence suggest that this induction is dependent on inhibition of the Rho pathway and requires de novo transcription. Furthermore, promoter deletion and mutational analyses suggest that mevastatin induced KLF2 promoter activity through a single myocyte enhancer factor binding site. Finally, small-interfering RNA-mediated knockdown of KLF2 strongly attenuated the ability of mevastatin to increase eNOS and thrombomodulin accumulation in endothelial cells. Taken together, these observations indicate that statin-dependent induction of eNOS and thrombomodulin requires KLF2 and thereby provides a novel molecular target for modulating endothelial function in vascular disease.
  Circulation 09/2005; 112(5):720-6. · 14.74 Impact Factor